Woodstock Corp Bristol Myers Squibb CO Transaction History

Woodstock Corp

$1.03 Billion
Q3 2024

A detailed history of Woodstock Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Woodstock Corp holds 59,714 shares of BMY stock, worth $3.35 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

59,714

Previous 60,022 0.51%

Holding current value

$3.35 Million

Previous $2.49 Million 24.0%

% of portfolio

0.3%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$39.66 - $51.75 $12,215 - $15,939	-308 Reduced 0.51%	59,714 $3.09 Million
Q2 2024 Jul 08, 2024	SELL	$40.25 - $52.99 $771,512 - $1.02 Million	-19,168 Reduced 24.21%	60,022 $2.49 Million
Q1 2024 Apr 09, 2024	SELL	$47.98 - $54.4 $236,109 - $267,702	-4,921 Reduced 5.85%	79,190 $4.29 Million
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $822,123 - $981,020	-16,958 Reduced 16.78%	84,111 $4.32 Million
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $2.65 Million - $2.96 Million	-45,775 Reduced 31.17%	101,069 $5.87 Million
Q2 2023 Jul 07, 2023	SELL	$63.71 - $70.74 $139,970 - $155,415	-2,197 Reduced 1.47%	146,844 $9.39 Million
Q1 2023 Apr 06, 2023	BUY	$65.71 - $74.53 $6,111 - $6,931	93 Added 0.06%	149,041 $10.3 Million
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $284,192 - $336,523	4,150 Added 2.87%	148,948 $0
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $131 - $77,838	-1,013 Reduced 0.69%	144,798 $10.3 Million
Q2 2022 Jul 11, 2022	BUY	$72.62 - $79.98 $8,133 - $8,957	112 Added 0.08%	145,811 $11.2 Million
Q1 2022 Apr 07, 2022	SELL	$61.48 - $73.72 $469,645 - $563,147	-7,639 Reduced 4.98%	145,699 $10.6 Million
Q4 2021 Jan 07, 2022	BUY	$53.63 - $62.52 $537,372 - $626,450	10,020 Added 6.99%	153,338 $9.56 Million
Q3 2021 Oct 05, 2021	BUY	$59.17 - $69.31 $31,892 - $37,358	539 Added 0.38%	143,318 $8.48 Million
Q2 2021 Jul 06, 2021	BUY	$61.91 - $67.42 $42,284 - $46,047	683 Added 0.48%	142,779 $9.54 Million
Q1 2021 Apr 05, 2021	SELL	$59.34 - $66.74 $21,303 - $23,959	-359 Reduced 0.25%	142,096 $8.97 Million
Q4 2020 Jan 06, 2021	BUY	$57.74 - $65.43 $435,590 - $493,603	7,544 Added 5.59%	142,455 $8.84 Million
Q3 2020 Oct 02, 2020	SELL	$57.43 - $63.64 $4,766 - $5,282	-83 Reduced 0.06%	134,911 $8.13 Million
Q2 2020 Jul 07, 2020	BUY	$54.82 - $64.09 $51,695 - $60,436	943 Added 0.7%	134,994 $7.94 Million
Q1 2020 Apr 03, 2020	SELL	$46.4 - $67.43 $464 - $674	-10 Reduced 0.01%	134,051 $7.47 Million
Q4 2019 Jan 13, 2020	BUY	$49.21 - $64.19 $4.79 Million - $6.25 Million	97,320 Added 264.88%	134,061 $8.61 Million
Q3 2019 Oct 02, 2019	BUY	$42.77 - $50.71 $128,138 - $151,927	2,996 Added 8.88%	36,741 $1.86 Million
Q2 2019 Jul 03, 2019	BUY	$44.62 - $49.34 $8,924 - $9,868	200 Added 0.6%	33,745 $1.53 Million
Q1 2019 Apr 05, 2019	SELL	$45.12 - $53.8 $1,579 - $1,883	-35 Reduced 0.1%	33,545 $1.6 Million
Q4 2018 Jan 08, 2019	SELL	$48.76 - $63.23 $754,561 - $978,484	-15,475 Reduced 31.55%	33,580 $1.75 Million
Q3 2018 Oct 03, 2018	SELL	$55.19 - $62.25 $45,531 - $51,356	-825 Reduced 1.65%	49,055 $3.05 Million
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $40,424 - $50,384	-800 Reduced 1.58%	49,880 $2.76 Million
Q1 2018 Apr 19, 2018	BUY	$59.92 - $68.98 $472,169 - $543,562	7,880 Added 18.41%	50,680 $3.21 Million
Q4 2017 Jan 24, 2018	BUY	$59.94 - $65.35 $37,162 - $40,517	620 Added 1.47%	42,800 $2.62 Million
Q3 2017 Oct 06, 2017	BUY	$55.23 - $63.74 $2.33 Million - $2.69 Million	42,180	42,180 $2.69 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

News

Stay updated on Woodstock Corp with notifications on news.

Account